Furthermore, enzymes involved in NAD+ salvage, namely NAMPT and NMNAT2, were reported to show an altered expression in the spinal cord of ALS patients, suggesting deficits of this pathway in the human ALS pathology (Harlan et al, 2020). This evidence concerns the gene NMNAT2 and amyotrophic lateral sclerosis.